Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy* - Wikidata - awgldk - TriplyDB

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*

http://www.wikidata.org/entity/Q35293895

about

Sequence heterogeneity in NS5A of hepatitis C virus genotypes 2a and 2b and clinical outcome of pegylated-interferon/ribavirin therapy Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment.NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.Analysis of sequences of hepatitis C virus NS5A genotype 1 in HIV-coinfected patients with a null response to nitazoxanide or peg-interferon plus ribavirin.Polymorphisms of hepatitis C virus non-structural protein 5A and core protein and clinical outcome of pegylated-interferon/ribavirin combination therapy.Sequence heterogeneity of NS5A and core proteins of hepatitis C virus and virological responses to pegylated-interferon/ribavirin combination therapy.

P2860

Q34154593-ADE6E325-ECE6-416C-B13E-1CF955CDEB91 Q34896257-9D2E9FAF-BFA0-4449-97C3-2DE1DB7FF059 Q36414090-1CAA1C04-BDC9-4A9D-9F8C-20412F816B39 Q38224436-539DCEB5-C79D-496F-8641-E4E9C1A133F5 Q41841986-D87C59DF-49D6-4A7B-AB5C-A9E1EA7C2D0C Q42694877-16B0FC00-5CEB-4840-9968-6BDDEBCD51BF Q43034121-A07AB136-AD0D-4700-9F51-F79C2DC757D3 Q43034814-34F22279-AADF-4492-A154-13F978AA52D3

P2860

Evolution of hepatitis C virus NS5A region in breakthrough patients during pegylated interferon and ribavirin therapy*

http://www.wikidata.org/entity/Q35293895

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@ast

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@en

type

label

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@ast

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@en

prefLabel

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@ast

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@en

P1433

Q35293895-CFAD2D8A-267C-4045-A612-B51AEEED7E64

P1476

Q35293895-F8A9BA43-3874-450F-81AC-10B4706CD905

P2093

Q35293895-12F1234B-EF5F-4A13-9A9A-FD9AD2098528

Q35293895-39B6E661-2BC3-40FA-83F8-5F9D38DD4ABC

Q35293895-4C74CF1F-8BDA-4677-ADB8-4C1E8057F7BB

Q35293895-7551BC1D-08A1-4F34-AB71-2BE94A853EF7

Q35293895-B2503589-283B-47DA-ACE3-0C53B304FA81

P2860

Q35293895-0C651880-B5B3-4CF0-983C-6DA41B7D3616

Q35293895-110BAF78-F65A-4A8A-965D-8D6303D807A5

Q35293895-170429D5-EFC2-403E-A12C-E46A92CE451D

Q35293895-192D7ADD-1E4C-477B-BAED-20F6DA4673CB

Q35293895-1C0F4D49-AA4F-412E-96BB-1F58834C0683

Q35293895-3106BA5A-2433-461C-AA9E-A0ACC7FC77C7

Q35293895-3511961B-DBD1-4482-976A-F6B40A2E8D2B

Q35293895-3F71CD9C-08A6-4660-9E50-E9D9B94E298A

Q35293895-42D6B049-4A03-49F7-B3FC-D2D322562E03

Q35293895-43A52351-FBC3-48B6-8480-DFF50806C7E3

P304

Q35293895-BC0CF481-92B1-4870-9224-E87DA91245F6

P31

Q35293895-65655F67-8BC0-4DBF-B9B4-481A2334EB08

P356

Q35293895-0C3E66ED-FCB7-4463-970C-E476E0BA2E09

P433

Q35293895-A47DFD14-DA7E-4D2A-BF93-83384B958238

P478

Q35293895-B9E6DDA2-39A0-4D7B-8483-2D289B620504

P50

Q35293895-1F6CE07C-3E7B-4427-81D2-A9BED7F196F3

P577

Q35293895-4695581B-F9C9-4169-8FE1-8DCEFE0B2F98

P5875

Q35293895-F120B74D-FBA3-4938-B0DA-FFDA62EFB756

P698

Q35293895-0B83FF95-F1BD-4303-89ED-8E3B101E1B51

P932

Q35293895-0775F533-3141-42A5-B5C3-AFE7270D1499

P356

J.1365-2893.2009.01169.X

P1433

Journal of Viral Hepatitis

P1476

Evolution of hepatitis C virus ...... erferon and ribavirin therapy*

@en

P2093

H J Yuan

http://www.w3.org/2001/XMLSchema#string

HALT-C Trial Group

http://www.w3.org/2001/XMLSchema#string

K K Snow

http://www.w3.org/2001/XMLSchema#string

M Jain

http://www.w3.org/2001/XMLSchema#string

W M Lee

http://www.w3.org/2001/XMLSchema#string

P2860

NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

Subversion of Cell Signaling Pathways by Hepatitis C Virus Nonstructural 5A Protein via Interaction with Grb2 and P85 Phosphatidylinositol 3-Kinase

Conserved Determinants for Membrane Association of Nonstructural Protein 5A from Hepatitis C Virus and Related Viruses

Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy

Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein

P304

208-216

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2893.2009.01169.X

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26718474

http://www.w3.org/2001/XMLSchema#string

P698

19656286

http://www.w3.org/2001/XMLSchema#string

P932

3189487

http://www.w3.org/2001/XMLSchema#string